Pulmonx Corporation LUNG Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 75.5%+2.0pp | 74.2%+0.2pp | 73.3%-0.9pp | 73.1%-1.1pp | 73.5%-0.8pp | |
| Operating margin | -58.8%+7.2pp | -59.3%+9.6pp | -62.4%+11.0pp | -62.9%+14.5pp | -66%+16.3pp | |
| Net margin | -60.1%+5.2pp | -59.7%+7.6pp | -61.9%+10.1pp | -62.9%+12.7pp | -65.3%+15.2pp | |
| Returns | ||||||
| Return on equity | -86.2%-25.5pp | -77.2%-21.9pp | -73.7%-21.7pp | -66.9%-17.7pp | -60.7%-14.5pp | |
| Return on invested capital | -92.1%-22.2pp | -89.6%-25.3pp | -82.2%-22.7pp | -74.1%-14.9pp | -69.9%-8.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.1× | 0.6×+0.1× | 0.6×+0.1× | 0.6×+0.1× | 0.6×+0.2× | |
| Liquidity | ||||||
| Current ratio | 4.9×-0.1× | 5.1×-0.5× | 4.9×-2.8× | 5.3×-3.6× | 5×-2.0× | |
| Leverage | ||||||
| Debt-to-equity | 1.2×+0.5× | 1×+0.4× | 0.9×+0.3× | 0.8×+0.3× | 0.7×+0.4× | |
| Per Share | ||||||
| Book value per share | $1.09-43.8% | $1.33-39.4% | $1.47-38.7% | $1.71-34.2% | $1.94-32.0% | |
| Valuation | ||||||
| Market capitalization | $54.91M-47.3% | $91.16M-66.0% | $66.01M-79.6% | $108.49M-55.7% | $267.83M-25.2% | |
| Price / sales | 0.6×-0.5× | 1×-2.2× | 0.7×-3.4× | 1.2×-2.0× | 3.1×-1.8× | |
| Price / book | 1.2×-0.3× | 1.7×-1.4× | 1.1×-2.3× | 1.6×-0.9× | 3.4×+0.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulmonx Corporation's profit margins?
- Pulmonx Corporation (LUNG) runs a 75.5% gross margin and a -58.8% operating margin, with a -60.1% net margin.
- Where do Pulmonx Corporation's ratios come from?
- Every ratio is computed from Pulmonx Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
